Approval · Notice of Compliance 13779 · 2012
IBUPROFEN: Notice of Compliance 13779
Issued October 29, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13779
- Date
- October 29, 2012
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Additional product name
- Therapeutic class
- Non-steroidal anti-inflammatory drug, analgesic, antipyretic
- Canadian reference product
- SUPER STRENGTH MOTRIN IB (Mcneil Consumer Healthcare)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IBUPROFEN | 02395169 | Approved |
Medicinal ingredients
- IBUPROFEN 400 MG per TAB